Clinical Trial Update: An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome

View source ↗

Summary

An observational study update on long-term Dacogen (decitabine) treatment in patients with Myelodysplastic Syndromes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Myelodysplastic Syndromes | Status: COMPLETED